Spok Holdings, Inc Q3 FY2026 earnings call

• Financial Performance: Delivered over 200% year-over-year increase in net income ($9.7 million) and nearly 30% increase in adjusted EBITDA ($8.6 million). Operating expenses fell more than 7% year-over-year to $26.1 million due to strategic realignment benefits.
• Strategic Pivot & Capital Allocation: Focus remains on profitable growth, cash generation, and returning capital to stockholders. The company returned $6.5 million in dividends in Q3 and expects to pay over $27 million in total dividends for 2026. Since inception, nearly $750 million has been returned to shareholders.
• Customer Success: Executed 42 six-figure and seven-figure contracts in the first nine months of 2026. Notable renewals include a major Midwest healthcare system (expanding to ~4,500 users) and a top-ranked pediatric hospital in the Southeast. Spoke serves all 11 children's hospitals and 18 of 20 adult hospitals on the 2026-2027 US News Honor Roll.
• Asset Monetization: Successfully closed the sale of narrowband spectrum licenses to CensusUSA for $8 million, generating over $7.5 million in cash after costs. Cash and equivalents totaled $30.1 million at quarter-end.
• Leadership & AI: Appointed Shiv Gopalakrishnan as EVP and General Manager to lead engineering, product strategy, and sales under one roof. Management is focusing on AI to accelerate product development and improve operational efficiencies.
• R&D Investment: Invested nearly $10 million in R&D during the first nine months of 2026, an 8% increase from 2025, supporting the CareConnect Suite and other internal uses.

The transcript does not provide a detailed breakdown of financial performance by specific product segment (e.g., Software vs. Wireless) in terms of absolute revenue contribution percentages for the quarter. However, it highlights that total software revenue was $16 million (flat year-over-year), while wireless revenue experienced a year-over-year decline, though the rate of decline improved by 220 basis points. Adjusted EBITDA was $8.6 million, up nearly 30% year-over-year.

• Full Year 2026 Guidance: Reiterated full-year 2026 financial guidance estimates for revenue and adjusted EBITDA as previously stated in the press release.
• Cash Balance Expectation: Anticipates exiting 2026 with approximately $28 million to $32 million in cash and cash equivalents, driven by the license sale proceeds and reduced working capital needs in the second half of the year.

• Revenue Decline Trends: Wireless revenue continues to decline due to unit loss, although ARPU improvements and pricing actions are partially offsetting this. Software bookings remain lumpy with longer decision cycles and a customer preference for shorter-term agreements.
• Backlog Structure: Software backlog (gross) decreased ~6% year-over-year to $67.7 million. A significant portion ($15.7 million) consists of cancelable obligations without significant penalty, reflecting tighter hospital budgets and flexibility demands. While historically few are canceled, this structure impacts how revenue visibility is assessed.
• Macroeconomic Environment: The company faces headwinds from an uncertain macroeconomic environment affecting customer spending and contract durations.

Q: Given the decline in wireless units and the shift toward shorter software contracts, how confident is management in sustaining the current EBITDA margins and free cash flow generation through the end of 2026?

A: Management expressed strong confidence, citing disciplined expense management and the completion of the strategic realignment which lowered operating costs by over 7%. They noted that while software bookings are lumpy, the high retention rates among their blue-chip customer base (including all top-tier children's hospitals) provide stability. Additionally, the monetization of assets like the spectrum sale demonstrates alternative avenues for cash generation beyond core operations.

Q: Can you elaborate on the impact of the new leadership structure combining engineering, product, and sales under Shiv Gopalakrishnan, and how this will specifically accelerate AI integration?

A: The consolidation aims to remove silos and speed up decision-making, allowing for faster iteration of the CareConnect Suite. By aligning commercial feedback directly with engineering, Spoke intends to reduce time-to-market for new AI-driven capabilities. This structure is designed to better leverage AI for operational efficiencies internally while enhancing product features that customers explicitly request, thereby driving both retention and new adoption.

Q: With the sale of the narrowband spectrum complete, what is the outlook for future asset monetization or potential use of the excess cash balance?

A: Management indicated that the spectrum sale validates the value of their intellectual property and spectrum holdings. While no immediate M&A plans were announced, the primary focus remains on returning capital to shareholders via dividends and share repurchases. The company views its extensive experience and asset base as tools for creating stockholder value, potentially through further selective monetization if opportunities arise that align with their capital allocation strategy.